Table 1.
Characteristics of surgical cases from which bone samples were collected
| Characteristics | Cases N = 100 |
Male | Female | p |
|---|---|---|---|---|
| Age (years) | 58.5 ± 17.2 | 58.2 ± 17.4 | 58.9 ± 17.1 | 0.852 |
| Gender, n (%) | ||||
| Male | 54 (54%) | |||
| Female | 46 (46%) | |||
| Height (cm) | 159.7 ± 9.2 | 164.9 ± 7.7 | 153.6 ± 6.9 | < 0.001 |
| Body weight (kg) | 60.7 ± 11.4 | 65.7 ± 10.0 | 54.9 ± 10.1 | < 0.001 |
| BMI (kg/m2) | 23.7 ± 3.4 | 24.1 ± 2.9 | 23.2 ± 3.9 | 0.210 |
| eGFR (mL/min/1.73 m2) | 83.4 ± 26.1 | 83.5 ± 23.4 | 83.2 ± 29.3 | 0.952 |
| Serum pentosidine concentration (μg/mL) | 0.05 ± 0.02 | 0.05 ± 0.02 | 0.05 ± 0.02 | 0.176 |
| Urinary pentosidine concentration (pmol/mg Cr) | 79.8 ± 40.8 | 71.7 ± 39.3 | 90.8 ± 40.8 | 0.056 |
| Bone pentosidine (mmol/mol of collagen) | 4.5 ± 2.5 | 4.8 ± 2.5 | 4.1 ± 2.4 | 0.202 |
| Skin pentosidine (mmol/mol of collagen) | 7.5 ± 3.5 | 6.9 ± 3.1 | 8.4 ± 3.8 | 0.051 |
| Skin AGE reader (AU) | 2.4 ± 0.5 | 2.4 ± 0.5 | 2.5 ± 0.5 | 0.488 |
Data are the mean ± standard deviation, unless otherwise indicated
AGE Advanced glycation end products, BMI Body mass index, Cr Creatinine, eGFR Estimated glomerular filtration rate
p-value: male versus females